Comparing the effects of Omega-3 Fatty Acids Supplement and Placebo in the treatment Patients with Methamphetamine-Induced Mood Disorder
Phase 2
- Conditions
- Methamphetamine-Induced Mood Disorder.Other stimulant use, unspecified with stimulant-induced mood disorderF15.94
- Registration Number
- IRCT20150822023705N13
- Lead Sponsor
- Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Methamphetamine dependence diagnoses according to Diagnostic and Statistical Manual of Mental Disorders fifth edition and TLC test
Methamphetamine-Induced Mood Disorder diagnoses accordingly Diagnostic and Statistical Manual of Mental Disorders fifth edition by a psychiatrist
The dominant use of methamphetamine for at least 6 months
Lack of serious psychiatric disorders
Exclusion Criteria
Disagreement to participate in the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method